LABCORP HOLDINGS INC (LH) Stock Price & Overview

NYSE:LH • US5049221055

Current stock price

262.57 USD
-1.85 (-0.7%)
Last:

The current stock price of LH is 262.57 USD. Today LH is down by -0.7%. In the past month the price decreased by -7.32%. In the past year, price increased by 14.96%.

LH Key Statistics

52-Week Range209.375 - 293.72
Current LH stock price positioned within its 52-week range.
1-Month Range261.2 - 290.65
Current LH stock price positioned within its 1-month range.
Market Cap
21.636B
P/E
15.97
Fwd P/E
14.37
EPS (TTM)
16.44
Dividend Yield
1.09%

LH Stock Performance

Today
-0.7%
1 Week
-0.91%
1 Month
-7.32%
3 Months
+4.15%
Longer-term
6 Months -5.77%
1 Year +14.96%
2 Years +21.04%
3 Years +15.26%
5 Years +3.68%
10 Years +125.75%

LH Stock Chart

LABCORP HOLDINGS INC / LH Daily stock chart

LH Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to LH. When comparing the yearly performance of all stocks, LH is one of the better performing stocks in the market, outperforming 70.63% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

LH Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to LH. LH has only an average score on both its financial health and profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

LH Earnings

On February 17, 2026 LH reported an EPS of 4.07 and a revenue of 3.52B. The company beat EPS expectations (0.26% surprise) and missed revenue expectations (-4.07% surprise).

Next Earnings DateApr 27, 2026
Last Earnings DateFeb 17, 2026
PeriodQ4 / 2025
EPS Reported$4.07
Revenue Reported3.516B
EPS Surprise 0.26%
Revenue Surprise -4.07%

LH Forecast & Estimates

29 analysts have analysed LH and the average price target is 309.93 USD. This implies a price increase of 18.04% is expected in the next year compared to the current price of 262.57.

For the next year, analysts expect an EPS growth of 11.11% and a revenue growth 4.86% for LH


Analysts
Analysts82.76
Price Target309.93 (18.04%)
EPS Next Y11.11%
Revenue Next Year4.86%

LH Groups

Sector & Classification

LH Financial Highlights

Over the last trailing twelve months LH reported a non-GAAP Earnings per Share(EPS) of 16.44. The EPS increased by 12.83% compared to the year before.


Income Statements
Revenue(TTM)13.95B
Net Income(TTM)876.50M
Industry RankSector Rank
PM (TTM) 6.28%
ROA 4.77%
ROE 10.17%
Debt/Equity 0.6
Chartmill High Growth Momentum
EPS Q2Q%17.97%
Sales Q2Q%5.6%
EPS 1Y (TTM)12.83%
Revenue 1Y (TTM)7.25%

LH Ownership

Ownership
Inst Owners99.89%
Shares82.40M
Float82.07M
Ins Owners0.34%
Short Float %3.91%
Short Ratio4.43

About LH

Company Profile

LH logo image Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company is headquartered in Burlington, North Carolina and currently employs 71,000 full-time employees. The firm operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The firm is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.

Company Info

IPO: 1991-04-24

LABCORP HOLDINGS INC

358 S Main St

Burlington NORTH CAROLINA 27215 US

CEO: Adam H. Schechter

Employees: 65450

LH Company Website

LH Investor Relations

Phone: 18009279800

LABCORP HOLDINGS INC / LH FAQ

What does LABCORP HOLDINGS INC do?

Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company is headquartered in Burlington, North Carolina and currently employs 71,000 full-time employees. The firm operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The firm is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.


What is the current price of LH stock?

The current stock price of LH is 262.57 USD. The price decreased by -0.7% in the last trading session.


Does LH stock pay dividends?

LABCORP HOLDINGS INC (LH) has a dividend yield of 1.09%. The yearly dividend amount is currently 2.91.


What is the ChartMill rating of LABCORP HOLDINGS INC stock?

LH has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


What sector and industry does LABCORP HOLDINGS INC belong to?

LABCORP HOLDINGS INC (LH) operates in the Health Care sector and the Health Care Providers & Services industry.


Is LABCORP HOLDINGS INC (LH) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on LH.


What is the outstanding short interest for LABCORP HOLDINGS INC?

The outstanding short interest for LABCORP HOLDINGS INC (LH) is 3.91% of its float.